These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26136670)

  • 21. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the kynurenine pathway in human glioma pathophysiology.
    Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
    PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
    Ceresoli-Borroni G; Guidetti P; Amori L; Pellicciari R; Schwarcz R
    J Neurosci Res; 2007 Mar; 85(4):845-54. PubMed ID: 17279543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
    Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
    Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils.
    Gigler G; Szénási G; Simó A; Lévay G; Hársing LG; Sas K; Vécsei L; Toldi J
    Eur J Pharmacol; 2007 Jun; 564(1-3):116-22. PubMed ID: 17407777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kynurenine metabolism in Alzheimer's disease.
    Baran H; Jellinger K; Deecke L
    J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats.
    Baratta AM; Viechweg SS; Mong JA; Pocivavsek A
    J Vis Exp; 2018 Aug; (138):. PubMed ID: 30176006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
    Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
    Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylmercuric chloride induces activation of neuronal stress circuitry and alters exploratory behavior in the mouse.
    Cooper JF; Kusnecov AW
    Neuroscience; 2007 Sep; 148(4):1048-64. PubMed ID: 17764854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dorsal CA1 interneurons contribute to acute stress-induced spatial memory deficits.
    Yu JY; Fang P; Wang C; Wang XX; Li K; Gong Q; Luo BY; Wang XD
    Neuropharmacology; 2018 Jun; 135():474-486. PubMed ID: 29626564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation by kynurenine of extracellular kynurenate and glutamate in cerebral cortex of rats with acute liver failure.
    Hilgier W; Kocki T; Obara-Michlewska M; Turski WA; Oja SS; Saransaari P; Albrecht J
    Pharmacol Rep; 2014 Jun; 66(3):466-70. PubMed ID: 24905525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary hydrogenated vegetable fat exacerbates the activation of kynurenine pathway caused by peripheral lipopolysaccharide immune challenge in aged mice.
    de Gomes MG; Souza LC; Boeira SP; Goes AR; Del Fabbro L; Filho CB; Donato F; Puntel RL; Jesse CR
    Chem Biol Interact; 2018 Sep; 293():28-37. PubMed ID: 30053448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens.
    Giménez-Gómez P; Pérez-Hernández M; Gutiérrez-López MD; Vidal R; Abuin-Martínez C; O'Shea E; Colado MI
    Neuropharmacology; 2018 Jun; 135():581-591. PubMed ID: 29705534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.
    Ishii K; Ogaya T; Song Z; Iizuka H; Fukushima T
    Chirality; 2010 Nov; 22(10):901-6. PubMed ID: 20872665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kynurenine pathway: a missing piece in the puzzle of valproate action?
    Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Kołosowska K; Lehner M; Płaźnik A
    Neuroscience; 2013 Mar; 234():135-45. PubMed ID: 23305763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
    Ceresoli-Borroni G; Rassoulpour A; Wu HQ; Guidetti P; Schwarcz R
    J Neural Transm (Vienna); 2006 Oct; 113(10):1355-65. PubMed ID: 16465454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus.
    Sas K; Robotka H; Rózsa E; Agoston M; Szénási G; Gigler G; Marosi M; Kis Z; Farkas T; Vécsei L; Toldi J
    Neurobiol Dis; 2008 Nov; 32(2):302-8. PubMed ID: 18761090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats.
    Vorwerk CK; Kreutz MR; Dreyer EB; Sabel BA
    Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2382-92. PubMed ID: 8933755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.